- |||||||||| etonogestrel/ethinylestradiol intravaginal ring / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity (clinicaltrials.gov) - Dec 10, 2018 P4, N=120, Completed, Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Nov 2018
- |||||||||| Trial completion, Trial completion date, Adherence: Cervical Cancer Screening Among Hispanic Women (clinicaltrials.gov) - Nov 13, 2018
P=N/A, N=451, Completed, Phase classification: P1 --> P1/2 Active, not recruiting --> Completed | Trial completion date: Jul 2019 --> Jul 2018
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (clinicaltrials.gov) - Nov 7, 2018
P=N/A, N=154, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Role of Metabolomics in the Diagnosis of Endometriosis (clinicaltrials.gov) - Nov 6, 2018
P=N/A, N=54, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018 Active, not recruiting --> Completed | N=40 --> 54 | Trial primary completion date: Mar 2016 --> Jun 2016
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal: Clinical Pregnancy Rate After Removal of Unsuspected Polyps (clinicaltrials.gov) - Nov 6, 2018
P3, N=0, Withdrawn, Active, not recruiting --> Completed | N=40 --> 54 | Trial primary completion date: Mar 2016 --> Jun 2016 N=200 --> 0 | Initiation date: Dec 2017 --> Jan 2017 | Not yet recruiting --> Withdrawn
- |||||||||| Menopur (menotropin) / Ferring
Trial completion, Phase classification, Trial completion date, Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Oct 29, 2018 P=N/A, N=126, Completed, Recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jan 2018 --> Apr 2016 | Trial primary completion date: Nov 2017 --> Mar 2016
- |||||||||| Trial completion, Phase classification, Trial completion date, Trial primary completion date: Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women (clinicaltrials.gov) - Oct 29, 2018
P=N/A, N=100, Completed, Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jan 2018 --> Apr 2016 | Trial primary completion date: Nov 2017 --> Mar 2016 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jul 2017 --> Mar 2018 | Trial primary completion date: Jul 2017 --> Dec 2017
- |||||||||| Trial completion, Trial completion date, Trial primary completion date, Head-to-Head: SALPINGOVA: Effect of Salpingectomy During Conservative Hysterectomy (clinicaltrials.gov) - Oct 22, 2018
P=N/A, N=350, Completed, Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 | Trial primary completion date: Aug 2017 --> May 2017
- |||||||||| progesterone / Generic mfg.
Trial completion, Enrollment change: Intrauterine Insemination and Luteal Fase Support (clinicaltrials.gov) - Oct 19, 2018 P4, N=393, Completed, Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 | Trial primary completion date: Aug 2017 --> May 2017 Enrolling by invitation --> Completed | N=198 --> 393
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: KINVAV: Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix (clinicaltrials.gov) - Oct 12, 2018
P3, N=327, Completed, N=10 --> 2 | Trial completion date: Nov 2017 --> Apr 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2017 --> Apr 2018 Recruiting --> Completed | Trial completion date: Oct 2017 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018
- |||||||||| Imfinzi (durvalumab) / AstraZeneca
Trial completion date, Trial termination: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (clinicaltrials.gov) - Oct 10, 2018 P2, N=4, Terminated, Recruiting --> Completed | Trial completion date: Jun 2017 --> Apr 2018 | Trial primary completion date: Jun 2017 --> Apr 2018 Trial completion date: Dec 2021 --> Jan 2018 | Active, not recruiting --> Terminated; Low accrual, funding withdrawn by AstraZeneca, and change in clinical practice
- |||||||||| PD 360324 / Pfizer
Trial completion date, Trial initiation date, Trial primary completion date: PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Oct 10, 2018 P2, N=15, Not yet recruiting, Trial completion date: Dec 2021 --> Jan 2018 | Active, not recruiting --> Terminated; Low accrual, funding withdrawn by AstraZeneca, and change in clinical practice Trial completion date: Sep 2021 --> Dec 2020 | Initiation date: Sep 2018 --> Dec 2018 | Trial primary completion date: Sep 2020 --> Dec 2020
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Assessment of Performance of [18F]-FES for Endometriosis Diagnosis (clinicaltrials.gov) - Sep 17, 2018
P2, N=31, Terminated, Recruiting --> Active, not recruiting | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018 N=100 --> 31 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Apr 2016; not enough enrollement
|